# A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis

> **NCT02016885** · PHASE2 · COMPLETED · sponsor: **Journey Medical Corporation** · enrollment: 198 (actual)

## Conditions studied

- Hyperhidrosis

## Interventions

- **DRUG:** glycopyrrolate, 1.0%
- **DRUG:** glycopyrrolate, 2.0%
- **DRUG:** glycopyrrolate, 3.0%
- **DRUG:** glycopyrrolate, 4.0%
- **OTHER:** Vehicle

## Key facts

- **NCT ID:** NCT02016885
- **Lead sponsor:** Journey Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 198 (ACTUAL)
- **Last updated:** 2021-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02016885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02016885, "A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02016885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*